Literature DB >> 25162903

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.

Lambros Kordelas1, Jens Verheyen, Dietrich W Beelen, Peter A Horn, Andreas Heinold, Rolf Kaiser, Rudolf Trenschel, Dirk Schadendorf, Ulf Dittmer, Stefan Esser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25162903     DOI： 10.1056/NEJMc1405805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  66 in total

1.  Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.

Authors:  Renier Myburgh; Sandra Ivic; Michael S Pepper; Gustavo Gers-Huber; Duo Li; Annette Audigé; Mary-Aude Rochat; Vincent Jaquet; Stephan Regenass; Markus G Manz; Patrick Salmon; Karl-Heinz Krause; Roberto F Speck
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.

Authors:  Li Liu; Bhavik Patel; Mustafa H Ghanem; Virgilio Bundoc; Zhili Zheng; Richard A Morgan; Steven A Rosenberg; Barna Dey; Edward A Berger
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

3.  HIV reservoirs as obstacles and opportunities for an HIV cure.

Authors:  Tae-Wook Chun; Susan Moir; Anthony S Fauci
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

Review 4.  Cell-based gene therapy against HIV.

Authors:  R Dey; B Pillai
Journal:  Gene Ther       Date:  2015-06-16       Impact factor: 5.250

5.  Second example reported of a stem-cell transplant in the clinic leading to HIV remission.

Authors:  Timothy J Henrich
Journal:  Nature       Date:  2019-04       Impact factor: 49.962

6.  Immunochemical engineering of cell surfaces to generate virus resistance.

Authors:  Jia Xie; Devin Sok; Nicholas C Wu; Tianqing Zheng; Wei Zhang; Dennis R Burton; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

7.  A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Authors:  Xiaoran Tang; Hongliang Jin; Yue Chen; Li Li; Yuanmei Zhu; Huihui Chong; Yuxian He
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

8.  Clinical Applications of Genome Editing to HIV Cure.

Authors:  Cathy X Wang; Paula M Cannon
Journal:  AIDS Patient Care STDS       Date:  2016-11-17       Impact factor: 5.078

Review 9.  CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.

Authors:  Michelle B Kim; Kyle E Giesler; Yesim A Tahirovic; Valarie M Truax; Dennis C Liotta; Lawrence J Wilson
Journal:  Expert Opin Investig Drugs       Date:  2016-12       Impact factor: 6.206

10.  Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.

Authors:  Yosuke Maeda; Taichiro Takemura; Takayuki Chikata; Takeo Kuwata; Hiromi Terasawa; Riito Fujimoto; Nozomi Kuse; Tomohiro Akahoshi; Hayato Murakoshi; Giang Van Tran; Yu Zhang; Chau Ha Pham; Anh Hong Quynh Pham; Kazuaki Monde; Tomohiro Sawa; Shuzo Matsushita; Trung Vu Nguyen; Kinh Van Nguyen; Futoshi Hasebe; Tetsu Yamashiro; Masafumi Takiguchi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.